1 BTC
=
- USD
Forian Inc. Common Stock
As of May 30, 2026 at 24:05 UTC
Chart
About Forian Inc. Common Stock
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.
Market Statistics
Trading Metrics
How to Buy FORA
Create Your Account
Sign up, deposit BTC, and transfer it to your Unified Trading Account. It only takes a moment.
Start Your Trade
From Terminal, click Trade Now on the asset you want to buy. You'll be purchasing its tokenized asset.
Buy FORA
Enter the amount and confirm your purchase. That's it! You'll see the impact of the trade in your Unified Trading Account.
New to Tokenized Assets? Learn more in our Help Center.
Latest News
5 articlesHalper Sadeh LLC, an investor rights law firm, is investigating four companies for potential securities law violations and breaches of fiduciary duties related to proposed mergers and acquisitions. The firm is examining whether McCormick & Company's merger with Unilever's Foods business, Odyssey Marine Exploration's merger with American Ocean Minerals Corporation, Soleno Therapeutics' sale to Neurocrine Biosciences, and Forian Inc.'s sale to a consortium led by its CEO are providing fair consideration to shareholders. The firm suggests insiders may receive substantial benefits unavailable to ordinary shareholders and seeks increased consideration and additional disclosures on behalf of investors.
Halper Sadeh LLC, an investor rights law firm, is investigating four companies for potential securities law violations and breaches of fiduciary duties related to their proposed acquisitions. The firm is examining whether shareholders are receiving fair consideration and whether insider benefits may be prioritized over ordinary shareholder interests.
Halper Sadeh LLC, an investor rights law firm, is investigating four companies for potential violations of federal securities laws and breaches of fiduciary duties. The investigations concern Soleno Therapeutics' sale to Neurocrine Biosciences, Forian's sale to a consortium led by its CEO, McCormick & Company's merger with Unilever's Foods business, and Cyclerion Therapeutics' merger with Korsana Biosciences. The firm is seeking increased consideration and additional disclosures on behalf of shareholders.
Forian Inc. reported Q3 2024 financial results, with revenue decreasing 12% year-over-year and net loss from continuing operations of $0.2 million. The company acquired Kyber Data Science and redeemed convertible notes during the quarter.
Forian Inc. (FORA) will announce its Q3 2024 financial results on November 13, 2024. The company provides data science-driven solutions to the healthcare and life sciences industries.